tiprankstipranks
BeOne Medicines Ltd (HK:6160)
:6160
Hong Kong Market
6160
BeOne Medicines Ltd
RESEARCH TOOLSreports

BeOne Medicines Ltd (6160) Income Statement

22 Followers

BeOne Medicines Ltd Income Statement

Last quarter (Q4 2025), BeOne Medicines Ltd's total revenue was $1.50B, an increase of 32.72% from the same quarter last year. In Q4, BeOne Medicines Ltd's net income was $66.44M. See BeOne Medicines Ltd’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 5.35B$ 3.81B$ 2.46B$ 1.42B$ 1.18B
Gross Profit
$ 4.56B$ 3.22B$ 2.08B$ -511.06M$ -447.86M
Operating Expenses
$ 4.12B$ 3.78B$ 3.29B$ 1.28B$ 990.87M
Depreciation and Amortization
$ 141.90M$ 171.76M$ 87.67M$ 66.28M$ 46.46M
EBITDA
$ 589.69M$ -396.44M$ -1.12B$ -1.72B$ -1.39B
Operating Income
$ 447.80M$ -568.20M$ -1.21B$ -1.79B$ -1.44B
Other Income/Expenses
$ -30.33M$ 35.20M$ 381.90M$ -171.37M$ 147.00K
Pretax Income
$ 417.47M$ -533.00M$ -825.84M$ -1.96B$ -1.44B
Net Income
$ 287.36M$ -644.79M$ -881.71M$ -2.00B$ -1.46B
Per Share Metrics
Basic EPS
$ 0.20$ -0.47$ -0.65$ -1.49$ -1.17
Diluted EPS
$ 0.20$ -0.47$ -0.65$ -1.49$ -1.17
Weighted Average Shares Outstanding
 1.42B 1.37B 1.36B 1.34B 1.21B
Weighted Average Shares Outstanding (Diluted)
 1.47B 1.37B 1.36B 1.34B 1.21B
Currency in USD

BeOne Medicines Ltd Earnings and Revenue History